The Academy posted a news article last month about an FDA effort to solicit patient feedback specifically in the area of “treatments for moderate to severe hearing loss (implanted vs. other treatment options).” To that end, the Academy’s Government Relations Committee authored the Patient Survey so that practitioners could print the document and provide it to their patients. The survey document includes specific instructions so that patients can complete the survey and then mail their responses directly to the FDA.
The FDA is hoping to glean from this feedback whether patients prefer certain outcomes or choices over others in terms of their health. In addition, the FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risk and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.
Patient feedback should be postmarked on or before July 2, 2019.
Related Posts
CMS Issues Final Rule to Improve Access, Accountability, and Transparency in Medicaid Managed Care
The Centers for Medicare and Medicaid (CMS) recently issued a final rule aimed at improving access to care, accountability and transparency for the more than 70…
April 2024 State Legislative Update
In early April, as 19 state legislatures concluded their sessions for the year, a flurry of legislative activity marked the landscape, particularly in audiology and…
Medicare Advantage Plans Now Required to Inform Beneficiaries of Hearing Benefits
On April 4, 2024, the Centers for Medicare and Medicaid Services (CMS) issued a final rule that updates the Medicare Advantage Program for 2025. In…